Highlights Mangoceuticals, Inc.

Equities

MGRX

US56270V1061

Market Closed - Nasdaq Other stock markets 20:59:47 04/06/2024 BST			5-day change	1st Jan Change
0.371 ^USD	+6.00%		-15.68%	+33.98%

02:00pm	Mangorx to Introduce ?Mojo? Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances	CI
05-21	Sector Update: Health Care Stocks Advance Late Afternoon	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mangorx to Introduce ?Mojo? Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances	01:00pm	CI
Sector Update: Health Care Stocks Advance Late Afternoon	05-21	MT
Sector Update: Health Care	05-21	MT
Top Midday Gainers	05-21	MT
Mangoceuticals, Inc. to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications	05-21	CI
Mangoceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15	CI
Mangoceuticals Signs Securities Purchase Deal; Mexican Unit Enters Technical Deal With Emifarma	04-12	MT
Top Premarket Gainers	03-20	MT
Certain Common Stock of Mangoceuticals, Inc. are subject to a Lock-Up Agreement Ending on 18-MAR-2024.	03-17	CI
Certain Warrants of Mangoceuticals, Inc. are subject to a Lock-Up Agreement Ending on 18-MAR-2024.	03-17	CI
Certain Options of Mangoceuticals, Inc. are subject to a Lock-Up Agreement Ending on 18-MAR-2024.	03-17	CI
Mangoceuticals, Inc. Officially Launches ?PRIME? by MangoRx, Powered by Kyzatrex® FDA Approved Oral Testosterone Replacement Therapy Treatment	03-12	CI
Mangoceuticals, Inc. Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth	02-20	CI
Mangoceuticals, Inc. Accepting Pre Orders for its PRIME	02-05	CI
Mangoceuticals, Inc. to Introduce ?Prime?, Powered by Kyzatrex® (Ciii Testosterone Undecanoate Capsules), for an FDA Approved Oral Testosterone Replacement Therapy Product	12-13	CI
Mangoceuticals Expands its Men's Health Product Line with Compounded Hair Growth Treatment 'Grow' by MangoRx	11-16	CI
Mangoceuticals, Inc. Launches New Sildenafil Based Erectile Dysfunction Product with Signature Mango Flavor & Rapid Dissolve	16/08/23	CI
Mangoceuticals Shares Rise Following Announcement of Collaboration With RedLime Solutions	01/08/23	MT
Mangoceuticals, Inc. Collaborates with Ice Shaker to Launch Mango Branded Ice Shaker Protein Bottles	29/06/23	CI
Mangoceuticals, Inc. Announces Upcoming Launch of Its Sildenafil Based Mango Flavored Rapid Dissolve ED Product	21/06/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Mangoceuticals, Inc.

Equities

MGRX

US56270V1061

Highlights

Filters